Clinical Trials Directory

Trials / Unknown

UnknownNCT01886092

Repetitive Transcranial Magnetic Stimulation as a Treatment for Tinnitus

Verification of the Usefulness of the Repetitive Transcranial Magnetic Stimulation in the Treatment of Chronic Tinnitus

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
80 (estimated)
Sponsor
Seoul National University Hospital · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

Efficacy of different protocols of transcranial magnetic stimulation for the treatment of tinnitus

Detailed description

Repetitive transcranial magnetic stimulation (rTMS) of the dorsolateral prefrontal cortex has an add-on effect for primary auditory cortex rTMS in improving tinnitus-related distress. The investigators aimed to investigate whether rTMS of the dorsolateral prefrontal cortex and primary auditory cortex are capable of reducing tinnitus loudness.

Conditions

Interventions

TypeNameDescription
DEVICEActive rTMS 1repetitive transcranial magnetic stimulation (Figured 8-Coil Cool-B65): 1000 stimuli of 1Hz rTMS over the left dorsolateral prefrontal cortex (110% motor threshold) followed by 2000 stimuli of 1 Hz rTMS over the left primary auditory cortex (110% motor threshold), each consisting of 4 days of rTMS treatment. (20 subjects).
DEVICEActive rTMS 2repetitive transcranial magnetic stimulation (Figured 8-Coil MCF-B65): 3000 stimuli of 1 Hz rTMS over the left temporal cortex (110% motor threshold), each consisting of 4 days of rTMS treatment. (20 subjects)
DEVICEActive rTMS 3repetitive transcranial magnetic stimulation (Figured 8-Coil MCF-B65): 3000 stimuli of 1 Hz rTMS over the left dorsolateral prefrontal cortex (110% motor threshold) each consisting of 4 days of rTMS treatment. (20 subjects)
DEVICEsham conditionSham rTMS, applied with the same combination of parameters as active rTMS, except for the number of stimulations per session. (20 subjects)

Timeline

Start date
2013-05-01
Primary completion
2019-09-01
Completion
2020-10-01
First posted
2013-06-25
Last updated
2018-10-09

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT01886092. Inclusion in this directory is not an endorsement.